Trxade Health Q1 EPS $(6.40) Down From $(0.45) YoY
Portfolio Pulse from Benzinga Newsdesk
Trxade Health (NASDAQ:MEDS) reported a significant increase in quarterly losses, with Q1 EPS at $(6.40), a 1322.22% decrease from $(0.45) per share in the same period last year.
June 27, 2024 | 12:03 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Trxade Health reported a significant increase in quarterly losses, with Q1 EPS at $(6.40), a 1322.22% decrease from $(0.45) per share in the same period last year.
The substantial increase in quarterly losses is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100